2013
DOI: 10.4103/0300-1652.122328
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant activated factor VII in post partum haemorrhage

Abstract: Post-partum haemorrhage (PPH) is a life-threatening obstetric complication and the leading cause of maternal death. Any bleeding that results in or could result in haemodynamic instability, if untreated, must be considered as PPH. There is no controversy about the need for prevention and treatment of PPH. The keystone of management of PPH entails first, non-invasive and nonsurgical methods and then invasive and surgical methods. However, mortality remains high. Therefore, new advancements in the treatment are … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…rFVIIa can be considered as second-line haemostatic therapy alongside intra-uterine tamponade, uterine compression sutures, pelvic vessel ligation and interventional radiology 925,926 . Case reports 927–931 and retrospective studies 926,932–936 support off-label use of rFVIIa for severe obstetric coagulopathic bleeding. Additional observational studies report increased risk of thrombosis 937,938 …”
Section: Discussionmentioning
confidence: 99%
“…rFVIIa can be considered as second-line haemostatic therapy alongside intra-uterine tamponade, uterine compression sutures, pelvic vessel ligation and interventional radiology 925,926 . Case reports 927–931 and retrospective studies 926,932–936 support off-label use of rFVIIa for severe obstetric coagulopathic bleeding. Additional observational studies report increased risk of thrombosis 937,938 …”
Section: Discussionmentioning
confidence: 99%
“…rFVIIa can be considered as second-line haemostatic therapy alongside intrauterine tamponade, uterine compression sutures, pelvic vessel ligation and interventional radiology. 302 Case reports [303][304][305] and retrospective studies 302,306-309 support off-label use of rFVIIa for severe obstetric coagulopathic bleeding.…”
Section: Guiding Therapy In Obstetric Bleeding Recommendationmentioning
confidence: 99%